Bright Minds Biosciences Inc (NASDAQ:DRUG) shares are trading higher again after soaring last week. The company on Monday ...

Bright Minds Biosciences (TSE:DRUG) has released an update. Bright Minds Biosciences is teaming up again with Firefly Neuroscience to analyze ...

Bright Minds Biosciences (DRUG) announced that it is once again collaborating with Firefly Neuroscience (AIFF), an Artificial Intelligence ...

Bright Minds Biosciences is working with Firefly Neuroscience, an AI healthcare company, to provide a full analysis of the electroencephalogram data in Bright Minds' Phase 2 clinical trial evaluating ...

Firefly Neuroscience partners with Bright Minds Biosciences to analyze positive Phase 1 data of BMB-101 using advanced AI ...

As Firefly Neuroscience, Inc. (NASDAQ:AIFF) advances its AI-driven Brain Network Analytics technology and collaborates with Bright Minds Biosciences, investors should be aware of some key ...

Shares of Bright Minds Biosciences on Friday shot higher after pricing a $35 million private placement. The stock was up 70% at $36.86 in pre-market trading. The company said it has priced the ...

Bright Minds is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. Bright Minds has a portfolio of next-generation serotonin agonists ...

NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug ...

Now with 4,109 faculty, Duke remains a destination for bright minds, a place to build lasting connections. Vice Provost for Faculty Advancement Abbas Benmamoun, who joined Duke in 2017, said he often ...

1 Day DRUG 949.20% DJIA -0.77% Russell 2K 0.63% Health Care/Life Sciences -0.05% ...

TORONTO - Firefly Neuroscience, Inc. (NASDAQ:AIFF), a company specializing in artificial intelligence (AI) solutions for neurological and mental disorders, announced a collaboration with Bright Minds ...